Terumo Launches SurTract™ Safety Syringe in the United States, Powered by Roncadelle Operations' SafeR® Passive Safety Technology
- New, retractable safety hypodermic line offers enhanced safety, reliability and ease of use while minimizing patient discomfort* - SOMERSET, N.J., Jan. 6, 2026 /PRNewswire/ -- Terumo Medical Corporation, a wholly-owned subsidiary of Terumo Corporation, announced the US launch of its SurTract(TM) Safety Syringe, powered by SafeR(R) passive safety technology developed by Roncadelle Operations S.r.l. The SurTract Syringe will be distributed across hospitals, clinics, and emergency-care...